Deep Sequencing Reveals Myeloma Cells in Peripheral Blood in Majority of Multiple Myeloma Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Deep Sequencing Reveals Myeloma Cells in Peripheral Blood in Majority of Multiple Myeloma Patients

Published:2014-04 Issue:2 Volume:14 Page:131-139.e1
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Vij Ravi,Mazumder Amitabha,Klinger Mark,O'Dea Denise,Paasch Jacob,Martin Thomas,Weng Li,Park Jeesun,Fiala Mark,Faham Malek,Wolf Jeffrey

Funder

Sequenta, Inc

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference38 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Improved survival in multiple myeloma and the impact of novel therapies;Kumar;Blood,2008

3. Latest advances and current challenges in the treatment of multiple myeloma;Mahindra;Nat Rev Clin Oncol,2012

4. Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma;Srivastava;Leukemia,2013

5. Lenalidomide-prednisone induction followed by lenalidomide-melphalan-prednisone consolidation and lenalidomide-prednisone maintenance in newly diagnosed elderly unfit myeloma patients;Falco;Leukemia,2013

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Loss of Heterozygosity and Mutations in the RAS-ERK Pathway Genes in Tumor Cells of Various Loci in Multiple Myeloma;International Journal of Molecular Sciences;2024-08-30

2. Measurable residual disease (MRD)-testing in haematological cancers: A giant leap forward or sideways?;Blood Reviews;2024-08

3. Measurable Residual Disease and Decision-Making in Multiple Myeloma;Hematology/Oncology Clinics of North America;2024-04

4. Modern approaches to assessment of minimal residual disease in multiple myeloma (plasma cell myeloma) cases;Medicine of Extreme Situations;2023-12

5. Prospective evaluation of minimal residual disease in the phase II FORTE trial: a head-to-head comparison between multiparameter flow cytometry and next-generation sequencing;eClinicalMedicine;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3